• Aker Capital entered a forward contract covering 10,707,629 shares in Aker BioMarine, representing 12.21% of votes.
• As of Aug. 18, Aker Capital held 69,065,940 shares, equal to 78.73% of shares and voting rights.
• Counterparty will acquire the shares from the cash offer, with physical settlement due by Dec. 1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aker BioMarine ASA published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.